Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$17.60 -0.62 (-3.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Change in Accured Expenses (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Change in Accured Expenses of $18.77 million in Q2 2026, up 4.8% from $17.9 million a year earlier.

Analysis

Syndax Pharmaceuticals (SNDX) Change in Accured Expenses (2015 - 2026) Analysis & Trends

On a TTM basis, Syndax Pharmaceuticals' Change in Accured Expenses came in at $17.22 million as of Jun 30, 2026, down 64.2% year-over-year; for FY2025, it was $42.17 million, up 120.3% from FY2024.

  • Annual Change in Accured Expenses has increased for five straight years, with a five-year compound annual growth rate of 136.7% (FY2020 to FY2025).
  • Across earlier years, Change in Accured Expenses came in at $19.14 million in FY2024 (+28.7%), $14.87 million in FY2023 (+57.8%), $9.42 million in FY2022 (+240.2%) and $2.77 million in FY2021 (+388.4%).
  • Quarterly Change in Accured Expenses has ranged from -$28.35 million in Q1 2026 to $25.7 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Change in Accured Expenses rose in four of the last five quarters, with growth averaging 26.9%.
  • Peak year-over-year performance for Change in Accured Expenses in the last five years was growth of 207.3% in Q3 2021, against a decline of 94.8% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -$28.35 million (Q1 2026), $25.7 million (Q4 2025) and $1.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Syndax Pharmaceuticals 1.57 Bn -160.92 Mn 69.58 Mn 18.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.77 Mn
Mar 31, 2026 -28.35 Mn
Dec 31, 2025 25.70 Mn
Sep 30, 2025 1.10 Mn
Jun 30, 2025 17.90 Mn
Mar 31, 2025 -2.53 Mn
Dec 31, 2024 11.66 Mn
Sep 30, 2024 21.04 Mn
Jun 30, 2024 -6.84 Mn
Mar 31, 2024 -6.71 Mn
Dec 31, 2023 7.50 Mn
Sep 30, 2023 14.16 Mn
Jun 30, 2023 2.38 Mn
Mar 31, 2023 -9.17 Mn
Dec 31, 2022 10.97 Mn
Sep 30, 2022 -3.86 Mn
Jun 30, 2022 -1.54 Mn
Mar 31, 2022 3.86 Mn
Dec 31, 2021 638,000.00
Sep 30, 2021 1.90 Mn
API Access

Syndax Pharmaceuticals Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=SNDX&period=max&api_key=YOUR_API_KEY